The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer’s Disease-Reference-Cited by-同舟云学术

The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer’s Disease

Published:2012-06 Issue:3 Volume:16 Page:135-141
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Engelborghs Sebastiaan,Le Bastard Nathalie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF03262201.pdf

Reference53 articles.

1. Alzheimer’s Disease International. The global prevalence of dementia. In: Prince M, Jackson J, editors. World Alzheimer report 2009. London: Alzheimer’s Disease International; 2009: 25–46

2. Alzheimer’s Association, Thies W, Bleiler L. 2011 Alzheimer’s disease facts and figures. Alzheimers Dement 2011 Mar; 7 (2): 208–44.

3. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984 Jul; 34 (7): 939–44.

4. Knopman DS, Dekosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001 May; 56 (9): 1143–53.

5. The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and the National Institute on Aging Working Group. Consensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” [published erratum appears in Neurobiol Aging 1998 May–Jun; 19 (3): 285]. Neurobiol Aging 1998 Mar; 19 (2): 109–16.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Raman spectroscopy and machine learning for biomedical applications: Alzheimer’s disease diagnosis based on the analysis of cerebrospinal fluid;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2021-03

2. Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer’s Disease;Journal of Alzheimer's Disease;2019-01-22

3. Golgin A4 in CSF and granulovacuolar degenerations of patients with Alzheimer disease;Neurology;2018-10-10

4. Drug treatments in Alzheimer’s disease;Clinical Medicine;2016-06

5. Magnetic resonance T2 relaxation time at 7 Tesla associated with amyloid β pathology and age in a double-transgenic mouse model of Alzheimer’s disease;Neuroscience Letters;2016-01